Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge acts for A.P. Møller - Mærsk A/S in connection with the takeover bid for Broström AB
Mandate

Vinge acts for A.P. Møller - Mærsk A/S in connection with the takeover bid for Broström AB

August 27, 2008

Vinge is acting for A.P. Møller - Mærsk A/S in connection with the public offer to the shareholders of Broström AB (publ). The combination of the companies will create the world’s leading product tanker company. Broström is listed on the OMX Nordic Exchange Stockholm. Vinge assists with corporate, capital markets and labour advice. Based on the bid price (SEK 57 per share), Broström is valued to in total SEK 3.62 billion.

The Vinge team includes, inter alia, Göran Nyström (project manager), Pontus Enquist, Mattias Friberg, Jesper Schönbeck, Dain Nevonen, Emil Hedberg and Johan Syrén. Björn Lindskog, Fredrik Dahl och Björn Petersson assist regarding labour law issues.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026